Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SB 202026

Known as: SB-202026 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
We have investigated the pharmacology of the functionally selective muscarinic M1 receptor partial agonist, sabcomeline [SB… Expand
Is this relevant?
1999
1999
After S-AMPA (8.0 mM) lesions to the nucleus basalis and medial septal regions, at the source of the cortical and hippocampal… Expand
Is this relevant?
1998
1998
Abstract Sabcomeline, (SB-202026 [R-(Z)-α-(methoxyimino)-1-azabicyclo [2.2.2] octane-3-acetonitrile]), a functionally selective… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 5
Is this relevant?
1998
1998
1. Sabcomeline (SB-202026, 0.03 mg kg(-1), p.o.), a potent and functionally selective M1 receptor partial agonist, caused a… Expand
Is this relevant?
1997
1997
Loss of cholinergic function is believed to be implicated in the cognitive decline associated with senile dementia of the… Expand
Is this relevant?